Literature DB >> 11263923

An aldol approach to the synthesis of the EF fragment of spongistatin 1.

M T Crimmins1, J D Katz, L C McAtee, E A Tabet, S J Kirincich.   

Abstract

A synthesis of the C29-C51 fragment of spongistatin 1, containing the E and F rings, has been completed. The approach relies on four diastereoselective aldol additions and an asymmetric glycolate alkylation to establish eight of the eleven stereogenic centers. The intact chlorodiene side chain was appended by a Lewis acid catalyzed addition of an allylstannane to an epoxy enol ether.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11263923     DOI: 10.1021/ol015652m

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  6 in total

1.  Unified synthesis of C19-C26 subunits of amphidinolides B1, B2, and B3 by exploiting unexpected stereochemical differences in Crimmins' and Evans' aldol reactions.

Authors:  Wei Zhang; Rich G Carter; Alexandre F T Yokochi
Journal:  J Org Chem       Date:  2004-04-02       Impact factor: 4.354

2.  Amphidinolide B: total synthesis, structural investigation, and biological evaluation.

Authors:  Liang Lu; Wei Zhang; Sangkil Nam; David A Horne; Richard Jove; Rich G Carter
Journal:  J Org Chem       Date:  2013-02-13       Impact factor: 4.354

3.  (+)-Sorangicin A: evolution of a viable synthetic strategy.

Authors:  Amos B Smith; Shuzhi Dong; Richard J Fox; Jehrod B Brenneman; John A Vanecko; Tomohiro Maegawa
Journal:  Tetrahedron       Date:  2011-12-23       Impact factor: 2.457

4.  Diastereoselective synthesis of the pectenotoxin 2 non-anomeric AB spiroacetal.

Authors:  Danielle Vellucci; Scott D Rychnovsky
Journal:  Org Lett       Date:  2007-02-15       Impact factor: 6.005

5.  A hetero-Diels-Alder approach to complex pyrones: an improved synthesis of the spongistatin AB spiroketal.

Authors:  Michael T Crimmins; Aaron C Smith
Journal:  Org Lett       Date:  2006-03-02       Impact factor: 6.005

Review 6.  The Therapeutic Potential of Migrastatin-Core Analogs for the Treatment of Metastatic Cancer.

Authors:  Ernest Giralt; Daniele Lo Re
Journal:  Molecules       Date:  2017-02-09       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.